- Entry
- $3.13
- Now
- $2.88 -8.0%
- Target
- —
- Score
- —
Settle up first, because I posted a list of these in early August and one of them did something I genuinely did not see coming. CAPR I wrote it up at $4.20, right after the FDA advisory committee voted 9-3 against deramiocel and the stock had lost about 80% in three sessions. On Aug 24 the company said FDA extended the decision date to Nov 22 rather than ruling in August. They amended the BLA with another year of open …
— ORIGINAL POST ·
10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.
· r/pennystocks
· Sep 7, 2026